Penumbra Inc.: Medical Device Recalls in 2017

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by Penumbra Inc. in 2017. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.